Apex Capital Management’s Globus Medical GMED Stock Holding History

Apex Capital Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$7.08M	Buy	298,123 +46,042	+18%	+$1.13M	0.16%	133
2015 Q4	$7.01M	Buy	252,081 +19,262	+8%	+$484K	0.16%	128
2015 Q3	$4.81M	Buy	232,819 +18,887	+9%	+$478K	0.11%	152
2015 Q2	$5.49M	Buy	213,932 +26,797	+14%	+$679K	0.12%	145
2015 Q1	$4.72M	Buy	187,135 +43,328	+30%	+$1.06M	0.11%	151
2014 Q4	$3.42M	Buy	143,807 +36,847	+34%	+$816K	0.09%	160
2014 Q3	$2.1M	Buy	106,960 +10,379	+11%	+$214K	0.06%	170
2014 Q2	$2.31M	Buy	96,581 +16,219	+20%	+$391K	0.07%	171
2014 Q1	$2.14M	Buy	+80,362	New	+$1.91M	0.08%	172

Other funds holding GMED

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Apex Capital Management's GMED Position: Q1 2016 in Review

Apex Capital Management increased its Globus Medical (GMED) stake by 18% in Q1 2016, buying an estimated $1.13M and bringing the position to 298,123 shares worth $7.08M. The position accounts for 0.16% of the portfolio, ranked #133.

Apex Capital Management first reported a position in GMED in Q1 2014 and has held it in 9 quarters since. 204 funds tracked by Wall St. Rank hold GMED as of Q1 2016.

Apex Capital Management held 298,123 shares of Globus Medical worth $7.08M as of Q1 2016.
Apex Capital Management bought 46,042 Globus Medical shares in Q1 2016, an estimated $1.13M.
Globus Medical made up 0.16% of Apex Capital Management's portfolio in Q1 2016, its #133 holding.
Apex Capital Management first reported a position in Globus Medical in Q1 2014 and has held it in 9 quarters since.
204 funds tracked by Wall St. Rank held Globus Medical as of Q1 2016.

Based on Apex Capital Management's 13F filing for Q1 2016, filed 27 Apr 2016.